骨科指南

订阅

MedSci主页 / 所有栏目 / 骨科指南

《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读

2021-09-20 足踝外科电子杂志

腓骨肌萎缩症手足

Charcot-Marie-Tooth(CMT)病是一种遗传性的运动感觉神经病变,易引起高弓内翻足畸形。

中文标题：

《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读

发布机构：

发布日期：

2021-09-20

简要介绍：

Charcot-Marie-Tooth(CMT)病是一种遗传性的运动感觉神经病变,易引起高弓内翻足畸形。有关CMT病高弓内翻足治疗的高质量研究证据比较缺乏,因此,CMT病协会召集了经验丰富的足踝外科医生和神经病学家,基于发表的文献和个人经验,讨论了CMT病的诊疗和手术治疗的诸多事项,达成了《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》。该共识统一了CMT病高弓内翻足相关的专用术语,商定了病史和体格检查的标准,推荐了CMT病高弓内翻足畸形的综合治疗方案。本文从足踝外科医生这一角度对这部共识进行解读,对共识提到的几个临床上的重点内容进行了梳理,力争为国内同行提供一个简明、可操作的指引。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=da99b1c002302232, title=《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读, enTitle=, guiderFrom=足踝外科电子杂志, authorId=0, author=, summary=Charcot-Marie-Tooth(CMT)病是一种遗传性的运动感觉神经病变,易引起高弓内翻足畸形。, cover=https://img.medsci.cn/20211225/1640441914151_5579292.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Sep 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">Charcot-Marie-Tooth(CMT)病是一种遗传性的运动感觉神经病变,易引起高弓内翻足畸形。有关CMT病高弓内翻足治疗的高质量研究证据比较缺乏,因此,CMT病协会召集了经验丰富的足踝外科医生和神经病学家,基于发表的文献和个人经验,讨论了CMT病的诊疗和手术治疗的诸多事项,达成了《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》。该共识统一了CMT病高弓内翻足相关的专用术语,商定了病史和体格检查的标准,推荐了CMT病高弓内翻足畸形的综合治疗方案。本文从足踝外科医生这一角度对这部共识进行解读,对共识提到的几个临床上的重点内容进行了梳理,力争为国内同行提供一个简明、可操作的指引。&nbsp;</span></p>, tagList=[TagDto(tagId=35725, tagName=腓骨肌萎缩症), TagDto(tagId=86219, tagName=手足)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=35725, guiderKeyword=腓骨肌萎缩症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1883, appHits=36, showAppHits=0, pcHits=337, showPcHits=1847, likes=0, shares=6, comments=4, approvalStatus=1, publishedTime=Sat Dec 25 22:14:43 CST 2021, publishedTimeString=2021-09-20, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Dec 25 22:24:39 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 19:22:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读.pdf)])
《2020北美Charcot-Marie-Tooth病协会CMT病高弓内翻足管理共识》的解读.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1223232, encodeId=801c122323294, content=优秀优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=977d5569065, createdName=hztrue, createdTime=Sun May 29 21:21:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202528, encodeId=28cb120252897, content=好东西 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54cd73304, createdName=tigerxgj2008, createdTime=Mon Mar 14 16:57:12 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084310, encodeId=7f6f108431018, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 26 07:32:20 CST 2021, time=2021-12-26, status=1, ipAttribution=)]
    2022-05-29 hztrue

    优秀优秀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1223232, encodeId=801c122323294, content=优秀优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=977d5569065, createdName=hztrue, createdTime=Sun May 29 21:21:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202528, encodeId=28cb120252897, content=好东西 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54cd73304, createdName=tigerxgj2008, createdTime=Mon Mar 14 16:57:12 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084310, encodeId=7f6f108431018, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 26 07:32:20 CST 2021, time=2021-12-26, status=1, ipAttribution=)]
    2022-03-14 tigerxgj2008

    好东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1223232, encodeId=801c122323294, content=优秀优秀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=977d5569065, createdName=hztrue, createdTime=Sun May 29 21:21:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202528, encodeId=28cb120252897, content=好东西 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54cd73304, createdName=tigerxgj2008, createdTime=Mon Mar 14 16:57:12 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084310, encodeId=7f6f108431018, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 26 07:32:20 CST 2021, time=2021-12-26, status=1, ipAttribution=)]
    2021-12-26 微探

    学习学习

    0

拓展阅读

临床实践指南：儿童腓骨肌萎缩症的管理

Neurology department, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia · 2022-02-09

腓骨肌萎缩症外科治疗专家共识

国际矫形与创伤外科学会中国部足踝外科学会 · 2022-09-15